ClinicalTrials.Veeva

Menu

Low-dose Radiotherapy in iNHL

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status and phase

Enrolling
Phase 2

Conditions

Low-dose Radiotherapy
Indolent Lymphoma

Treatments

Radiation: Low-dose radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05543070
CLCG-iNHL-01

Details and patient eligibility

About

The current study is a phase II multi-center single arm trial to evaluate the efficacy and safety of low-dose radiotherapy (3 Gy*4f) in indolent lymphoma.

Enrollment

73 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pathology proved iNHL
  • ECOG PS ≤3
  • Signed Informed consent

Exclusion criteria

  • History of radiotherapy at the same site
  • Primary malignant lymphoma of the gastrointestinal tract
  • CTV (Clinical Target Volume)>500ml
  • Others that researchers consider inappropriate

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

73 participants in 1 patient group

Low-dose Radiotherapy
Experimental group
Description:
Involved-site radiotherapy (3 Gy\*4f) in one week
Treatment:
Radiation: Low-dose radiotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems